Iluvien protects against neuroretinal loss

FORT LAUDERDALE, Fla. — Patients with diabetic retinopathy experienced less neuroretinal loss after receiving a fluocinolone acetonide implant, according to a speaker here.
“We found preclinical and clinical evidence that diabetic retinopathy is a neurodegenerative disease,” Alexander Eaton, MD, said at the Retina World Congress. “I believe this is a new way of looking at it. We found neuroretinal degeneration slowed after treatment with the fluocinolone implant.”
Eaton and colleagues examined the USER study and evaluated OCT data collected up to 3 years before

Full Story →